HCPLive Network

Healthcare Expenditure Has Slowed in the US

WEDNESDAY, July 2, 2014 (HealthDay News) -- The growth in US healthcare expenditure has slowed in recent years, coming some way toward closing the gap with other countries of the Organisation for Economic Co-operation and Development (OECD), according to an article in the health of Americans series published online July 1 in The Lancet.

Noting that healthcare expenditure growth has slowed dramatically in the United States in recent years, Luca Lorenzoni, from the OECD in Paris, and colleagues reviewed expenditure trends and key policies in the United States and five other high-spending OECD countries since 2000.

The authors note that much of the difference between the United States and other high-spending counties can be explained by higher health-sector prices, and that price dynamics are mainly responsible for the expenditure growth slowdown. Expenditure growth was similar in the United States and in other counties, although other countries did not face the same challenges in health coverage and could draw from a broader set of policies to control expenditure. Some of the factors responsible for the slowdown in health care expenditure included increasing rate of generic drug use, a shift from inpatient to outpatient hospital care, and price control measures.

"Tightening Medicare and Medicaid price controls on plans and providers, and leveraging the scale of the public programs to increase efficiency in financing and care delivery, might prevent a future economic recovery from offsetting the slowdown in health sector prices and expenditure growth," the authors write.

Full Text (subscription or payment may be required)

Copyright © 2014 HealthDay. All rights reserved.


Further Reading
Researchers assessed the effect of seizure status and severity, medication use, mental health indicators, parental support, and other factors on self-reported quality of life in children with epilepsy.
A group of international researchers led by Luosheng Li, MD, of the Rolf Luft Research Center for Diabetes and Endocrinology at the Karolinska Institutet, Karolinska University Hospital in Stockholm, Sweden, recently demonstrated that age-dependent decline in insulin secretion (and thus glucose homeostasis) from the beta cell in experimental mice models is associated with subtle changes in Ca2+ dynamics.
For patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD), the right treatment can make a world of difference in the management of their condition. A recent study looked at how effective inhaled budesonide and systemic methylprednisolone can be for those patients.
More Reading